OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy
Wai‐Ki Wong, Bohan Yin, Ching Ying Katherine Lam, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 23
Wai‐Ki Wong, Bohan Yin, Ching Ying Katherine Lam, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 23
Showing 23 citing articles:
Engineering multifunctional dynamic hydrogel for biomedical and tissue regenerative applications
Bohan Yin, Monika Gosecka, Mahdi Bodaghi, et al.
Chemical Engineering Journal (2024) Vol. 487, pp. 150403-150403
Open Access | Times Cited: 34
Bohan Yin, Monika Gosecka, Mahdi Bodaghi, et al.
Chemical Engineering Journal (2024) Vol. 487, pp. 150403-150403
Open Access | Times Cited: 34
Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway
Meng Zhu, Yingli Han, Tianning Gu, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114065-114065
Closed Access | Times Cited: 19
Meng Zhu, Yingli Han, Tianning Gu, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114065-114065
Closed Access | Times Cited: 19
Polymeric Nanoparticles—Tools in a Drug Delivery System in Selected Cancer Therapies
Marcel Madej, Natalia Kurowska, Barbara Strzałka‐Mrozik
Applied Sciences (2022) Vol. 12, Iss. 19, pp. 9479-9479
Open Access | Times Cited: 52
Marcel Madej, Natalia Kurowska, Barbara Strzałka‐Mrozik
Applied Sciences (2022) Vol. 12, Iss. 19, pp. 9479-9479
Open Access | Times Cited: 52
HMGB2 regulates the differentiation and stemness of exhausted CD8+ T cells during chronic viral infection and cancer
Emily N. Neubert, Julia M. DeRogatis, Sloan A. Lewis, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Emily N. Neubert, Julia M. DeRogatis, Sloan A. Lewis, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Cellular Dynamics of Tumor Microenvironment Driving Immunotherapy Resistance in Non-Small-Cell Lung Carcinoma
Shujie Huang, Jeff Yat‐Fai Chung, Chunjie Li, et al.
Cancer Letters (2024), pp. 217272-217272
Closed Access | Times Cited: 8
Shujie Huang, Jeff Yat‐Fai Chung, Chunjie Li, et al.
Cancer Letters (2024), pp. 217272-217272
Closed Access | Times Cited: 8
An Aggregation-Induced Emission-Based Dual Emitting Nanoprobe for Detecting Intracellular pH and Unravelling Metabolic Variations in Differentiating Lymphocytes
Yingying Huang, Qin Zhang, Ching Ying Katherine Lam, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15935-15949
Closed Access | Times Cited: 6
Yingying Huang, Qin Zhang, Ching Ying Katherine Lam, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15935-15949
Closed Access | Times Cited: 6
Production of Minor Ginsenoside CK from Major Ginsenosides by Biotransformation and Its Advances in Targeted Delivery to Tumor Tissues Using Nanoformulations
Mohanapriya Murugesan, Ramya Mathiyalagan, Vinothini Boopathi, et al.
Nanomaterials (2022) Vol. 12, Iss. 19, pp. 3427-3427
Open Access | Times Cited: 24
Mohanapriya Murugesan, Ramya Mathiyalagan, Vinothini Boopathi, et al.
Nanomaterials (2022) Vol. 12, Iss. 19, pp. 3427-3427
Open Access | Times Cited: 24
H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy
Chu Xiao, Tao Fan, Yujia Zheng, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 8, pp. e005693-e005693
Open Access | Times Cited: 16
Chu Xiao, Tao Fan, Yujia Zheng, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 8, pp. e005693-e005693
Open Access | Times Cited: 16
Nucleic Acid Armor: Fortifying RNA Therapeutics through Delivery and Targeting Innovations for Immunotherapy
Yi Jiang, Bolong Jiang, Zhenru Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8888-8888
Open Access | Times Cited: 5
Yi Jiang, Bolong Jiang, Zhenru Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8888-8888
Open Access | Times Cited: 5
Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives
Ibrahim S. Alalhareth, Saleh M. Alyami, Abdulrhman Alshareef, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 207-207
Open Access
Ibrahim S. Alalhareth, Saleh M. Alyami, Abdulrhman Alshareef, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 207-207
Open Access
Epigenetics in T-cell driven inflammation and cancer
Lea Falkowski, Joerg Buddenkotte, Angeliki Datsi
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 250-260
Closed Access | Times Cited: 8
Lea Falkowski, Joerg Buddenkotte, Angeliki Datsi
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 250-260
Closed Access | Times Cited: 8
Smart Design of Nanostructures for Boosting Tumor Immunogenicity in Cancer Immunotherapy
Bohan Yin, Wai‐Ki Wong, Yip-Ming Ng, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1427-1427
Open Access | Times Cited: 8
Bohan Yin, Wai‐Ki Wong, Yip-Ming Ng, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1427-1427
Open Access | Times Cited: 8
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
Nai-Jung Chiang, Kien Thiam Tan, Li‐Yuan Bai, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 19, pp. 4248-4257
Open Access | Times Cited: 12
Nai-Jung Chiang, Kien Thiam Tan, Li‐Yuan Bai, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 19, pp. 4248-4257
Open Access | Times Cited: 12
Hepatocellular carcinoma epi-immunotherapy with polyion complex micelles co-delivering HDAC8 inhibitor and PD-L1 siRNA
Jinhua Zhao, Taiqing Liu, Yinqi Li, et al.
Chemical Engineering Journal (2024), pp. 158138-158138
Closed Access | Times Cited: 2
Jinhua Zhao, Taiqing Liu, Yinqi Li, et al.
Chemical Engineering Journal (2024), pp. 158138-158138
Closed Access | Times Cited: 2
Promising use of immune cell‐derived exosomes in the treatment of SARS‐CoV‐2 infections
Murad Alahdal, Eyad Elkord
Clinical and Translational Medicine (2022) Vol. 12, Iss. 8
Open Access | Times Cited: 9
Murad Alahdal, Eyad Elkord
Clinical and Translational Medicine (2022) Vol. 12, Iss. 8
Open Access | Times Cited: 9
Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer Immunotherapy
Kenneth K.W. To, William C. Cho
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2166-2166
Open Access | Times Cited: 4
Kenneth K.W. To, William C. Cho
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2166-2166
Open Access | Times Cited: 4
Epigenetic regulatory mechanism of macrophage polarization in diabetic wound healing (Review)
Junying Song, Yuqing Wu, Yunli Chen, et al.
Molecular Medicine Reports (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Junying Song, Yuqing Wu, Yunli Chen, et al.
Molecular Medicine Reports (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
Anmin Huang, Bei Lv, Yunjie Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 3
Anmin Huang, Bei Lv, Yunjie Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 3
Reversal of T-cell exhaustion: Mechanisms and synergistic approaches
Yang Hu, Yaqi Zhang, Fenfen Shi, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112571-112571
Closed Access
Yang Hu, Yaqi Zhang, Fenfen Shi, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112571-112571
Closed Access
Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors
Katrin Mestermann, Andoni Garitano-Trojaola, Michael Hudecek
BioDrugs (2024)
Open Access
Katrin Mestermann, Andoni Garitano-Trojaola, Michael Hudecek
BioDrugs (2024)
Open Access
Widespread genomic de novo DNA methylation occurs following CD8 + T cell activation and proliferation
Annika R. Seddon, Olivia M. Damiano, Mark B. Hampton, et al.
Epigenetics (2024) Vol. 19, Iss. 1
Open Access
Annika R. Seddon, Olivia M. Damiano, Mark B. Hampton, et al.
Epigenetics (2024) Vol. 19, Iss. 1
Open Access
Sirtinol, a SIRT1 inhibitor, inhibits the EMT and metastasis of 4T1 breast cancer cells and impacts the tumor microenvironment
Sharvari Satam, Nitya Palekar, Kavitha Premkumar, et al.
Immunopharmacology and Immunotoxicology (2024) Vol. 46, Iss. 6, pp. 829-842
Closed Access
Sharvari Satam, Nitya Palekar, Kavitha Premkumar, et al.
Immunopharmacology and Immunotoxicology (2024) Vol. 46, Iss. 6, pp. 829-842
Closed Access
Modeling and Remodeling the Cell: How Digital Twins and HCMV Can Elucidate the Complex Interactions of Viral Latency, Epigenetic Regulation, and Immune Responses
Hana McMahon-Cole, Alicia Johnson, Sara Sadat Aghamiri, et al.
Current Clinical Microbiology Reports (2023) Vol. 10, Iss. 3, pp. 141-151
Open Access
Hana McMahon-Cole, Alicia Johnson, Sara Sadat Aghamiri, et al.
Current Clinical Microbiology Reports (2023) Vol. 10, Iss. 3, pp. 141-151
Open Access
